#Healthcare

Pharma Financial Supply Chain Software

Pharmaceutical companies are navigating increasingly complex financial operations as outsourcing grows, commercialization strategies evolve and pricing and reimbursement become more sophisticated. The next wave of purpose-built software could help modernize procurement, budgeting and gross-to-net execution while improving governance, reducing manual workflows and protecting margins.

LLR has spent over two decades investing in healthcare technology businesses and is watching the space closely. Companies and intermediaries working in this space should contact Will Sadock to discuss relevant investment opportunities.

The opportunity is to move from manual reconciliation after the fact to governed execution before leakage reaches the P&L.

Will Sadock, Vice President, LLR Partners

Tailwinds Accelerating Demand for Pharma Financial Operations Software

Increasing Procurement Complexity: As procurement teams continue to rely more heavily on CROs, CDMOs and external providers, they need more control over outsourced spend, contracts, and vendor relationships.

Increasing Clinical Planning Complexity: Clinical finance, R&D Finance, and FP&A teams must forecast clinical trial budgets despite constantly changing variables like vendor budget, protocol design, and patient timelines, increasing demand for dedicated planning software that transforms static budgets into dynamic, governed workflows.

 

Increasing Commercial & Pricing Complexity: As pricing rules, reimbursement models, and contracts become increasingly difficult to manage, pharmaceutical companies need better tools to manage rebates, chargebacks and government pricing. GTN software helps translate these complex pricing rules into controlled workflows that finance, commercial and compliance teams can trust.

 

The value proposition for pharma financial operations software

15-30%
1
improvement in off-contract purchasing associated with digital procurement
40-60%
2
list price associated with gross-to-net reductions

Key Focus Areas for LLR Investment

Our areas of focus span software that helps pharmaceutical organizations improve financial visibility, planning and governance across the drug development and commercialization lifecycle:

Procurement & Vendor Management, including software that streamlines supplier onboarding, sourcing, SOW management, contract approvals, vendor performance and outsourced R&D spend.

Clinical Financial Planning & Forecasting, including platforms connecting protocol assumptions, enrollment timelines, vendor budgets, amendments and actual spend into dynamic forecasting workflows.

Gross-to-Net & Commercial Finance, including vendors offering purpose-built platforms that transform RWD into RWE and mine client data for insights across clinical and commercial use-cases and consultancies offering tech-enabled offerings around life science data and analytics.

Financial Workflow & Governance, including software supporting rebate management, chargebacks, government pricing, 340B compliance, reimbursement analytics and gross-to-net forecasting.

Our Strategic Network

Portfolio companies gain access to LLR’s in-house Value Creation and Market Development resources, along with our extensive network of industry relationships, built over 25 years of investing in healthcare businesses.

Select Investment Experience

LLR invests in the sectors where our investment experience indicates there are attractive business models and market trends supporting strong growth potential. Here are some of our related investments.

Latest GrowthBits

View All
#Healthcare
Where Did the Margin Go? Modernizing Pharma’s Financial Supply Chain
William Sadock / Vice President

Meet the LLR Team

Zack Sigal

Zack Sigal
William Sadock

William Sadock
Tyler Wincig

Tyler Wincig
Dylan Kim

Dylan Kim
Ankush Somenhalli

Ankush Somenhalli
Charles Qu

Charles Qu

Related News

News

September 8, 2022

LLR Partners Announces Significant Growth Investment in VPL

LLR Partners today announced a significant growth investment in Vantage Point Logistics (“VPL”), a supply chain management software provider that helps...

News

July 1, 2015

Health Information Companies HealthPort and IOD Merge

Merger to create nation’s leading platform for secure clinical data solutions; positions company for continued innovation and growth. In May...

References

  1. “Digital Procurement Strategies and Transformation Future,” Akirolabs, 2025, https://www.akirolabs.com/blog/digital-procurement-strategies-transformation
  2. “Drug Channels Institute, “Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers,” July 23, 2024, https://www.drugchannels.net/2024/07/gross-to-net-bubble-update-2023-pricing.html
Disclaimer:

The information presented herein is intended for an audience of potential LLR portfolio companies and the intermediaries supporting their capital raise processes. Named LLR investments presented herein do not reflect a complete list of LLR investments and are provided for informational purposes only. Certain statements about LLR made by portfolio company executives and other quoted parties herein are intended to illustrate the work of LLR’s Value Creation Team with such portfolio companies or reflect the individual’s perspective on the featured industry sector. Such portfolio companies are controlled by investment vehicles managed by LLR. Quoted parties were not compensated in connection with their participation, although they generally receive compensation and investment opportunities in connection with their portfolio company or Senior Operating Advisor roles, and in certain cases are also owners of portfolio company securities and/or investors in LLR-sponsored vehicles. Such compensation and investments subject participants to potential conflicts of interest in making the statements herein.